SK life science announces FDA acceptance of NDA submission for cenobamate, an investigational antiepileptic drug

https://www.sklifescienceinc.com/wp-content/themes/sklifescience2020/old/pdf/SKLSI%20NDA%20Acceptance%20Press%20Release%20-FINAL-Updated%202-3-19.pdf